Interested in Cartistem Medipost? On this page, we have collected links for you, where you will receive the most necessary information about Cartistem Medipost.


CARTISTEM® - MEDIPOST

    http://www.medi-post.com/cartistem/
    CARTISTEM® – allogeneic umbilical cord blood-derived mesenchymal stem cells, is used for the treatment of knee cartilage defects in patients with Osteoarthritis (with ICRS grade* IV cartilage defect) caused by degeneration or repetitive trauma. *ICRS grade : A diagnostic criteria used for grading the severity of cartilage …

The Future of Biotechnology - MEDIPOST

    http://www.medi-post.com/
    CARTISTEM ® – allogeneic umbilical cord blood-derived mesenchymal stem cells, is used for the treatment of knee cartilage defects in patients with Osteoarthritis (with ICRS grade* IV cartilage defect) caused by degeneration or repetitive trauma.

COMPANY - MEDIPOST

    http://www.medi-post.com/intro/
    Today, MEDIPOST is leading the global stem cell therapeutics field with the world’s first regulatory-approved allogeneic human Umbilical Cord Blood-derived Mesenchymal Stem Cell (hUCB-MSC) product named CARTISTEM ® for patients with knee Osteoarthritis …

GMP Facility - MEDIPOST

    http://www.medi-post.com/gmp/
    MEDIPOST holds exclusive technologies relating to stem cell separation, cell characterization, mass culture while maintaining high cell viability, and cryopreservation, which are then applied to the manufacturing, storage and delivery logistics of cell therapeutics utilized in the field of …

[INTERVIEW] Medipost to unlock potential in …

    https://koreatimes.co.kr/www/tech/2019/12/694_279684.html
    Dec 04, 2019 · Medipost's Cartistem cartilage regeneration therapy / Courtesy of Medipost Buoyed by Cartistem's success, Medipost is now working on a new knee cartilage regeneration therapy. This …

Cartistem - Product Profile - BCIQ

    https://bciq.biocentury.com/products/cartistem
    Cartistem regulatory update...Medipost said the Korea Food and Drug Administration approved Cartistem to treat osteoarthritis.

Mesenchymal stem cell therapy for cartilage repair - Medipost

    https://adisinsight.springer.com/drugs/800034605
    Mar 01, 2021 · Mesenchymal stem cell therapy for cartilage repair - Medipost Alternative Names: Cartistem; SMUP-IA-01 Latest Information Update: 01 Mar 2021. Price : $50 * Buy Profile. Adis is an information provider. We do not sell or distribute actual drugs. Final gross price and currency may vary according to local VAT and billing address. ...

NEUROSTEM® - MEDIPOST

    http://www.medi-post.com/neurostem/
    MEDIPOST Initiates Phase-2 Clinical Trial of CARTISTEM in Japan 2020.09.21 MEDIPOST’s CEO Dr Yang Yoonsun Named on the Forbes 2020 List of Asia’s Power Businesswomen 2020.09.16 MEDIPOST Completes Phase 2a Clinical Trial of NEUROSTEM for Alzheimer’s Disease 2020.07.07

Home - Medipost Pharmacy

    https://medipost.co.za/
    Developing this opportunity led towards the establishment of Medipost as the first national pharmacy in South Africa, and this remains our core business today. We offer our nationwide customers their chronic medication and other healthcare products at competitive fees and distribute the medication to them by courier, at no additional cost.

Contact Us - Medipost Pharmacy

    https://medipost.co.za/contact-us/
    Medipost Gezina Walk-in Pharmacy Trading Hours: Weekdays – 08h00 to 17h00 (Except Wednesdays – 09h00 to 17h00) Saturdays – 08h00 to 12h00.

We hope you have found all the information you need about Cartistem Medipost through the links above.


Previous -------- Next

Related Pages